Peter Loftus

Thanks for having me.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Novo Nordisk, yesterday, the stock had the best session in about two and a half years.

Right. All right, have you heard of this so-called miracle drug Ozempic?

Right. All right, have you heard of this so-called miracle drug Ozempic?

Right. All right, have you heard of this so-called miracle drug Ozempic?

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.

Shares of Novo Nordisk plunging by the most on record today after disappointing data from its experimental obesity drug.